MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $584,160 | -52.3% | 4,000 | -24.6% | 0.01% | -56.2% |
| Q2 2023 | $1,224,762 | +1.6% | 5,302 | +6.5% | 0.02% | -5.9% |
| Q1 2023 | $1,205,728 | +90.6% | 4,977 | +128.4% | 0.02% | +70.0% |
| Q4 2022 | $632,455 | +110.6% | 2,179 | -76.4% | 0.01% | +233.3% |
| Q3 2022 | $300,300 | -21.4% | 9,242 | +73.1% | 0.00% | -62.5% |
| Q2 2022 | $382,000 | +39.4% | 5,340 | +89.7% | 0.01% | +300.0% |
| Q2 2021 | $274,000 | +24.5% | 2,815 | +16.8% | 0.00% | -50.0% |
| Q4 2019 | $220,000 | -12.7% | 2,410 | -17.4% | 0.00% | -42.9% |
| Q3 2019 | $252,000 | -36.0% | 2,918 | +58.7% | 0.01% | -50.0% |
| Q3 2018 | $394,000 | – | 1,839 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |